Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

A group of Victorian mothers have written to the health minister after struggling to get their children an antibody ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

RAHWAY, N.J., June 09, 2025--U.S. FDA Approves Merck’s ENFLONSIA for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season ...

Hospital tests eventually revealed that her 95-year-old mother Jane Tan (not her real name) had respiratory syncytial virus (RSV). “She couldn’t breathe at all,” recalls Ms Chua.

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory syncytial virus (RSV) causes infections of the breathing passages and lungs. It's so common that most children have been infected with the virus by age 2, according to the Mayo Clinic.